Stonepine Capital Management’s ACELYRIN SLRN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLRN
Stonepine Capital Management's SLRN Position: Q2 2025 in Review
Stonepine Capital Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 167,580 shares — an estimated $414K sold.
Stonepine Capital Management first reported a position in SLRN in Q4 2024 and held it in 2 quarters. The position peaked at $417K in Q4 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.
- Stonepine Capital Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
- Stonepine Capital Management sold 167,580 ACELYRIN shares in Q2 2025, an estimated $414K.
- Stonepine Capital Management first reported a position in ACELYRIN in Q4 2024 and held it in 2 quarters.
- Stonepine Capital Management's ACELYRIN position peaked at $417K in Q4 2024.
- 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.
Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.